<i>In-silico</i> design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer-Reference-Cited by-同舟云学术

In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer

Published:2023-08-30 Issue: Volume: Page:1-23
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Kumar Sunil¹^ORCID,Ali Iqra²^ORCID,Abbas Faheem³^ORCID,Rana Anurag⁴^ORCID,Pandey Sadanand⁵,Garg Manoj⁶,Kumar Deepak¹^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, India

2. Department of Biosciences, COMSATS University Islamabad, Islamabad, Pakistan

3. Key Lab of Organic Optoelectronics and Molecular Engineering of Ministry of Education, Department of Chemistry, Tsinghua University, Beijing, P. R. China

4. Yogananda School of Artificial Intelligence, Computers, and Data Sciences, Shoolini University, Solan, India

5. Department of Chemistry, College of Natural Science, Yeungnam University, Gyeongsan, Korea

6. Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, India

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2023.2252496

Reference100 articles.

1. Ligand efficiency indices for effective drug discovery

2. Role of Iodo-Substituted Subphthalocyanine (Subpcs) π-conjugated aromatic N-fused di-Iminoisonidole units on the performance of non-fullerene small organic solar cells